This data shows that PD mutations affect lysosomal activity in a cell and mutation type specific manner, with PRKN lof mutations reducing GCase activity only in ventral midbrain neurons, whereas the LRRK2 R1441G mutation reduced GCase activity only in cortical neurons. This evidence concerns the gene PRKN and Parkinson disease.